Fosamax, Alendronate News

The bone anabolic drug teriparatide is more effective than alendronate at increasing bone mineral density and preventing vertebral fractures in patients with glucocorticoid-induced osteoporosis, new research indicates.

New data enhance our understanding of the effects of some contraceptives and key SERMs on the skeletal health of users ACOG: Given the efficacy of DMPA, the drug may be a good option in some populations, despite its effects on bone density New vertebral fractures occurred at a rate of 2.3% among women taking denosumab, versus 7.2% among those ...

A recent study determined glucocorticoid-induced osteoporosis is now treatable with Teriparatide, a synthetic form of the human parathyroid hormone.

My mother ,71 years old, has been use Steroid drug for serious Asthma for many years.

Women who take a popular drug for osteoporosis appear to be at increased risk of atrial fibrillation, the most common heart rhythm disturbance that increases the risk of stroke.

According to the National Institute of Arthritis, Musculoskeletal and Skin Diseases , the bone thinning condition known as osteoporosis is a major public health threat for 44 million Americans, 68 percent of whom are women.

What do you think about when you think of bone health? Perhaps calcium, milk, Fosamax or Boniva? You may know that resistant type exercises help to keep your bones healthy.

Sunday - " light-duty day. Ahead: Week 19 of Increment 20. Oct 2: The Soyuz TMA-16 spacecraft approaches the International Space Station, carrying NASA astronaut Jeffrey Williams, Expedition 21 flight engineer; Russian cosmonaut Maxim Suraev, Soyuz commander and flight engineer; and spaceflight participant Guy Laliberte.

Thursday, 1 October 2009, 1:15 pm Press Release: PHARMAC 1 October 2009 Media release New medicines, savings result from agreement New funded treatments for HIV/AIDS and nausea, and a strengthened osteoporosis treatment have emerged from an agreement between PHARMAC and pharmaceutical company Merck Sharp & Dohme .

Receive a FREE osteoarthritis of the knee pamphlet. Find out new information about postmenopausal osteoporosis.

Underway: Week 18 of Increment 20. Off-duty day for the crew . FE-4 Robert Thirsk started out with the weekly U.S. "Bisphosphonates" biomedical countermeasures experiment, ingesting an Alendronate pill before breakfast.

The recent mistrial concerning claims that Merck's anti-osteoporosis drug Fosamax allegedly weakens jaw bone tissue reminds us of the rather complicated issues many older people face in dealing with bone density problems.

DEAR DR. DONOHUE: My doctor recently put me on Evista. I had a complete hysterectomy when I was 40 years old.

Main Category: Bones / Orthopaedics Also Included In: Breast Cancer Article Date: 15 Sep 2009 - 6:00 PDT Osteoporosis is a growing concern among breast cancer survivors and their doctors, because certain cancer drugs can cause bone loss.

A federal judge has declared a mistrial in a suit against the makers of Fosamax after jury deliberations turned contentious, resulting in shouting and a deadlock.

Merck & Co., Inc. said today that a mistrial was declared by U.S. District Court Judge John F. Keenan in Boles v. Merck , the first FOSAMAX case to go to trial.

A mistrial in the first trial in the Fosamax federal multi-district litigation would send both parties back to square one, uncertain about the value - if any - of the cases.

Women with osteoporosis are missing out on the best drugs for managing their condition because strict prescribing rules are distorting medical priorities, senior doctors said yesterday.

Osteoclasts on a vertebral bone in an osteoporosis sufferer. Photograph: Alan Boyde/Wellcome Trust Medical Photographic Library Thousands of British women are being denied modern drugs to treat a common bone-thinning disease because guidelines surrounding its use are too stringent, doctors warn.

Main Category: Bones / Orthopaedics Also Included In: Women's Health / Gynecology Article Date: 04 Sep 2009 New research has revealed a need for GPs to assess their patients' history more closely when prescribing for post-menopausal osteoporosis to reduce the risk of upper gastrointestinal side effects that could lead to treatment discontinuation.1 ...